News Archive - Nicole Mlynaryk

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

Brain Organoids Reveal in Detail the Harms of Prenatal Alcohol Exposure

UC San Diego researchers used human brain organoids to study the effects of prenatal alcohol exposure on neural development, revealing significant harms in molecular detail.

Genetic Score Predicts Risk of Lethal Prostate Cancer

Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.

Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some

UC San Diego researchers and others report that more than one-third of the COVID-19 patients who did not receive any treatment experienced complete resolution of symptoms for at least two consecutive days, but then subsequently reported a return of symptoms.

UC San Diego Joins National Trial to Test Drug for Treating MPOX

UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.

‘Leaky’ Activity of Mutated Enzyme Underlies Neurodegenerative Disease

UC San Diego study finds enhanced PKCγ activity drives spinocerebellar ataxia type 14; suggests inhibiting the enzyme may have therapeutic potential

First-Ever Mycobiome Atlas Describes Associations between Cancers and Fungi

An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas—a survey of 35 types of cancer and their associated fungi.

High R&D Isn’t Necessarily Why Drugs Are So Expensive

In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.

UC San Diego, Salk and Others Seek to Map the Human Brain Over a Lifetime

With a $126 million grant from the National Institutes of Health, a multi-institution team of researchers at UC San Diego, Salk Institute and elsewhere has launched a new Center for Multiomic Human Brain Cell Atlas to describe human brain cells in unprecedented detail over a lifetime.

How to Tell the Difference between Kawasaki Disease and MIS-C

A national team of scientists, led by researchers at UC San Diego, have created a machine-learning algorithm for diagnosing both MIS-C and Kawasaki disease, two similar pediatric inflammatory conditions with different treatments.